Balchem agrees to acquire vitamin K2 player Kappa Bioscience 14-Jun-2022 By Stephen Daniells New York-based Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.
